ArticleBreast cancer (Dove Medical Press)2025

Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study.

Liping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.